This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Will Reynolds-British American Merger be a Reality Soon?
by Zacks Equity Research
The highly anticipated tobacco merger between Reynolds American Inc. (RAI) and British American Tobacco (BTI) seem to have cleared the antitrust hurdles from the U.S authorities.
Top Research Reports on Wells Fargo, Altria and Dow
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), Altria (MO) and Dow Chemical (DOW).
Philip Morris Expects Lower Currency Woes, Raises FY View
by Zacks Equity Research
Tobacco giant, Philip Morris International Inc. (PM) has raised 2017 earnings guidance anticipating lower currency headwind for the year.
Tobacco Stocks Queued Up for Q4 Earnings Release: RAI, TPB
by Zacks Equity Research
The fourth-quarter earnings season is in full swing with almost 55% of the total S&P 500 members already having reported their quarterly results.
The Zacks Analyst Blog Highlights: General Electric, Altria, UnitedHealth, Caterpillar and Phillips 66
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Electric, Altria, UnitedHealth, Caterpillar and Phillips 66
Altria's (MO) Q4 Earnings Beat, Sales Miss; Gives FY17 View
by Zacks Equity Research
Altria Group Inc. (MO) is one of the leading manufacturers of cigarettes and smokeless tobacco products in the U.S.
Altria (MO) to Report Q4 Earnings: A Beat in the Cards?
by Zacks Equity Research
Altria Group Inc. (MO) is slated to release fourth-quarter and full-year 2016 results before the opening bell on Feb 1, 2016.
Reynolds Agrees to Merge with British American Tobacco
by Zacks Equity Research
Tobacco giant, Reynolds American Inc. (RAI) has finally agreed to the merger proposal of British American Tobacco (BTI), under which the latter will take over the remaining 57.8% of Reynolds for $49 billion.
Stock Market News for December 12, 2016
by Zacks Equity Research
Benchmarks finished in the green on Friday as recently beaten down sector saw an impressive rebound
Top Research Reports for November 14, 2016
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Berkshire Hathaway (BRK.B) and Altria (MO).
Top 7 Research Reports for July 11, 2016
by Sheraz Mian
Today's must-read reports are for Gilead (GILD), Altria (MO) and Qualcomm (QCOM).
Consumer Staples Stock Outlook - June 2016
by Zacks Equity Research
The traditionally defensive consumer staples sector had a strong start to 2016 and was one of the best performing sectors in the S&P 500 in Q1.